Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers

Clinical trial NCT02487095 · COMPLETED

Trial details

NCT number: NCT02487095
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small -Cell Lung Ovarian Neoplasms Small Cell Lung Carcinoma Uterine Cervical Neoplasms Carcinoma, Neuroendocrine Extrapulmonary Small Cell Cancer

Start date: 2015-07-30
Primary completion: 2021-02-24
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.